Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life

J Oncol Pharm Pract. 2019 Dec;25(8):2059-2060. doi: 10.1177/1078155219854125. Epub 2019 Jun 10.

Authors

Jacopo Giuliani¹, Vito Albanese², Giovanni Ponturo², Andrea Bonetti¹

Affiliations

¹ Department of Oncology, Mater Salutis Hospital, Legnago, Italy.
² Department of Pharmacology, Mater Salutis Hospital, Legnago, Italy.

PMID: 31181991
DOI: 10.1177/1078155219854125

No abstract available

Publication types

Letter